End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.99 CNY | -1.55% | +1.70% | +12.85% |
Apr. 16 | CR Double-Crane Pharmaceutical Gets Nod to Trial Semaglutide Injection | MT |
Mar. 26 | CR Double-Crane Pharma Unit Receives Approval for Epilepsy Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.85% | 2.96B | |
+27.92% | 672B | |
+26.40% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.42% | 217B | |
-9.28% | 204B | |
+6.17% | 199B | |
-8.58% | 149B |
- Stock Market
- Equities
- 600062 Stock
- News China Resources Double-Crane Pharmaceutical Co.,Ltd.
- CR Double-Crane Pharmaceutical to Buy 31% of Local Peer For $45.5 Million